{
  "created_at": "Sun Oct 31 20:49:15 +0000 2021",
  "id_str": "1454901047315640321",
  "full_text": "Covid-19 patients who were given the low-cost antidepressant fluvoxamine were significantly less likely to require hospitalization https://t.co/vpd3SlzQBo",
  "display_text_range": [
    0,
    154
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/vpd3SlzQBo",
        "expanded_url": "https://on.wsj.com/2ZD0vce",
        "display_url": "on.wsj.com/2ZD0vce",
        "indices": [
          131,
          154
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 40,
  "favorite_count": 76,
  "possibly_sensitive": false,
  "original_created_at": "Sun Oct 31 20:00:15 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "低価格の抗うつ剤フルボキサミンを投与されたCovid-19患者は、入院を必要とする確率が有意に低かった https://t.co/vpd3SlzQBo"
    },
    {
      "locale": "zh",
      "full_text": "给予低成本抗抑郁药氟伏沙明的Covid-19患者需要住院治疗的可能性明显降低 https://t.co/vpd3SlzQBo"
    },
    {
      "locale": "zh-Hant",
      "full_text": "給予低成本抗抑鬱藥氟伏沙明的Covid-19患者需要住院治療的可能性明顯降低 https://t.co/vpd3SlzQBo"
    }
  ]
}